Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.

Abstract

The recent article by Nielsen and colleagues [1] presents an interesting cross-sectional investigation on a subgroup of cancer patients that self-prescribed cannabinoids. The authors present a study with a high response rate (83%) among the 326 patients (13% of the total cohort) that had used a cannabis-based medicine. Notwithstanding the small sample size, it still constitutes an evaluable response rate, given that the use of cannabis for medicinal purposes in Denmark is permitted.